Description of the medicine: Neohaemodesum (Neohaemodesum)
Transparent liquid of light yellow color.
Neohemodesis differs from hemodesis in the molecular weight of polyvinylpyrrolidone used for its manufacture. Instead of a polymer with a molecular weight of 12,600 + 2,700, neo-hemodesis uses polyvinylpyrrolidone with a molecular weight of 8,000 + 2,000.
The decrease in the molecular weight of the polymer accelerates its excretion by the kidneys from the body and improves the detoxification properties of the drug.
As well as haemodesis, neohemodesis is administered intravenously.
Indications for use are the same as for haemodesis.
Contraindicated in severe cardiovascular failure, cerebral hemorrhage, severe allergies.
Release form: in bottles on 100; 200 and 400 ml.
The composition (molecular weight of polyvinylpyrrolidone), action, indications and contraindications for use are similar to neo-hemodesis, however, it differs from it by a slightly modified production technology.